487 related articles for article (PubMed ID: 9378180)
1. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
3. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
[TBL] [Abstract][Full Text] [Related]
5. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
[TBL] [Abstract][Full Text] [Related]
6. The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group.
Cancer Res; 1987 Nov; 47(21):5782-7. PubMed ID: 2822233
[TBL] [Abstract][Full Text] [Related]
7. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
[TBL] [Abstract][Full Text] [Related]
8. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
Zanetti A
Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus vaccine in The Gambia, West Africa: synergy between public health research and practice.
Ryder RW
Mt Sinai J Med; 1992 Nov; 59(6):487-92. PubMed ID: 1336128
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
Kirk GD; Bah E; Montesano R
Carcinogenesis; 2006 Oct; 27(10):2070-82. PubMed ID: 16679307
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study.
Montesano R
J Med Virol; 2002 Jul; 67(3):444-6. PubMed ID: 12116042
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of malignant liver tumors].
Rodella S; Picoco C
Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
[TBL] [Abstract][Full Text] [Related]
16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
19. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
20. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]